1 year return (CAGR)
47.51%
Eli Lilly CDR (CAD Hedged) Exchange (TO, CAD)
LLY.TO
41.12
+0.48 (+1.18%)
TO
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
0.00
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.60%
Growth years
1
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 41.00 |
| Daily high | 41.40 |
| Daily low | 40.73 |
| Daily Volume | 25K |
| All-time high | 45.88 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 0.25 |
| Ex-div date | 14 Aug 2026 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LLY.TO | S&P500 | |
| Current price drop from All-time high | -10.37% | -2.08% |
| Highest price drop | -36.25% | -56.47% |
| Date of highest drop | 8 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -9.97% | -10.68% |
| Avg time to new high | 11 days | 12 days |
| Max time to new high | 300 days | 1805 days |
News
Eli Lilly’s updated fair value estimate has shifted from US$1,297.31 to US$1,325.39, adding a fresh data point to an already closely watched price target range. This move sits alongside analyst price ...
September 20, 2026
The US Department of Health and Human Services will get a portion of the increased revenue if Pfizer Inc. is able to charge higher drug prices abroad, according to newly released documents.
September 19, 2026
Investing.com -- Artificial intelligence is moving beyond text generation into scientific research, creating investment opportunities across AI infrastructure, pharmaceuticals, nuclear fusion, industr...
September 19, 2026
It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company.
September 18, 2026
Readers weigh in on energy investments, retirees’ dilemma, a Social Security fix, lessons from 9/11, and the case for natural-gas company Equinor.
September 18, 2026
Eli Lilly (LLY) trades near $1,150, up about 52% over the past year, and is now worth more than a trillion dollars. At that size the easy read is that the big money has been made. But Lilly has barely...
September 18, 2026
Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a two-drug obesity combo, and the September 30 readout will reveal whether eloraTZP is a genuine franchise leap or an expensive gam...
September 18, 2026
Johnson & Johnson (JNJ) stock has returned about 57% over the past year, against about 17% for the S&P 500. On the earnings it has already banked, that price looks expensive. But those earnings carry ...
September 18, 2026
Healthcare stocks declined late Friday afternoon, with the NYSE Healthcare Index and the State Stree
September 18, 2026